• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

原花青素修饰的脂纳米粒作为禽流感 DNA 疫苗的传递载体。

Corosolic acid-modified lipid nanoparticles as delivery carriers for DNA vaccines against avian influenza.

机构信息

Shanghai Frontiers Science Center of Optogenetic Techniques for Cell Metabolism, School of Pharmacy, East China University of Science and Technology, 130 Meilong Road, Shanghai 200237, China.

Engineering Research Center of Pharmaceutical Process Chemistry, School of Pharmacy, East China University of Science and Technology, 130 Meilong Road, Shanghai 200237, China.

出版信息

Int J Pharm. 2023 May 10;638:122914. doi: 10.1016/j.ijpharm.2023.122914. Epub 2023 Apr 5.

DOI:10.1016/j.ijpharm.2023.122914
PMID:37028571
Abstract

Cholesterol (CHOL) is essential for developing lipid nanoparticles (LNPs) for gene delivery because it enhances membrane fusion and improves the delivery efficiency of gene cargos. An attractive pDNA carrier, corosolic acid (CA)-modified lipid nanoparticles (CLNPs), was developed by replacing CHOL in LNPs to deliver pDNA at various ratios of nitrogen groups to phosphate groups (N/P). The resultant CLNPs with a higher CHOL/CA ratio exhibited similar mean particle size, zeta potential, and encapsulation efficiency to those of LNPs. In comparison with LNPs, CLNPs (CHOL:CA ratio = 2:1) achieved increased cellular uptake and enhanced transfection efficacy while maintaining low cytotoxicity. In vivo results from chicken experiments demonstrated that CLNPs encapsulating DNA vaccines against avian influenza at a N/P ratio of 3 could elicit similar-level humoral and cellular immune responses compared with those of LNPs at a higher N/P ratio, thereby suggesting the induction of desirable immune effects using less ionizable lipids. Our study provides a reference for further research on the application of CA in LNPs for gene delivery, and the development of novel delivery systems for DNA vaccines against avian influenza.

摘要

胆固醇(CHOL)对于开发用于基因传递的脂质纳米颗粒(LNPs)至关重要,因为它可以增强膜融合并提高基因货物的传递效率。通过用在 LNPs 中取代 CHOL 的熊果酸(CA)修饰的脂质纳米颗粒(CLNPs)来开发有吸引力的 pDNA 载体,以各种氮基团与磷酸基团的比例(N/P)传递 pDNA。具有较高 CHOL/CA 比例的所得 CLNPs 表现出与 LNPs 相似的平均粒径、ζ电位和包封效率。与 LNPs 相比,CLNPs(CHOL:CA 比例=2:1)在保持低细胞毒性的同时,增加了细胞摄取并提高了转染功效。来自鸡实验的体内结果表明,与更高 N/P 比例的 LNPs 相比,用 N/P 比为 3 包封针对禽流感的 DNA 疫苗的 CLNPs 可以引起类似水平的体液和细胞免疫反应,从而表明使用较少可离子化脂质诱导理想的免疫效果。我们的研究为进一步研究 CA 在 LNPs 中的基因传递应用以及针对禽流感的新型 DNA 疫苗传递系统的开发提供了参考。

相似文献

1
Corosolic acid-modified lipid nanoparticles as delivery carriers for DNA vaccines against avian influenza.原花青素修饰的脂纳米粒作为禽流感 DNA 疫苗的传递载体。
Int J Pharm. 2023 May 10;638:122914. doi: 10.1016/j.ijpharm.2023.122914. Epub 2023 Apr 5.
2
Optimization of DOTAP/chol Cationic Lipid Nanoparticles for mRNA, pDNA, and Oligonucleotide Delivery.DOTAP/胆固醇阳离子脂质纳米粒用于 mRNA、pDNA 和寡核苷酸递药的优化。
AAPS PharmSciTech. 2022 May 9;23(5):135. doi: 10.1208/s12249-022-02294-w.
3
Delivery of self-amplifying mRNA vaccines by cationic lipid nanoparticles: The impact of cationic lipid selection.阳离子脂质纳米粒递送自我扩增 mRNA 疫苗:阳离子脂质选择的影响。
J Control Release. 2020 Sep 10;325:370-379. doi: 10.1016/j.jconrel.2020.06.027. Epub 2020 Jul 1.
4
Polyphosphate coated nanoparticles: Enzyme-activated charge-reversal gene delivery systems.多聚磷酸盐包覆纳米粒:酶激活的电荷反转基因递释系统。
Int J Pharm. 2023 Nov 5;646:123474. doi: 10.1016/j.ijpharm.2023.123474. Epub 2023 Oct 2.
5
delivery of plasmid DNA by lipid nanoparticles: the influence of ionizable cationic lipids on organ-selective gene expression.脂质纳米粒递送质粒 DNA:可离子化阳离子脂质对器官选择性基因表达的影响。
Biomater Sci. 2022 May 31;10(11):2940-2952. doi: 10.1039/d2bm00168c.
6
Formulating and Characterizing Lipid Nanoparticles for Gene Delivery using a Microfluidic Mixing Platform.采用微流控混合平台制备和表征用于基因传递的脂质纳米粒。
J Vis Exp. 2021 Feb 25(168). doi: 10.3791/62226.
7
Ionizable Lipid Nanoparticle-Mediated Delivery of Plasmid DNA in Cardiomyocytes.离子脂质纳米颗粒介导的质粒 DNA 在心肌细胞中的递送。
Int J Nanomedicine. 2022 Jun 30;17:2865-2881. doi: 10.2147/IJN.S366962. eCollection 2022.
8
Mechanistic Insights into the Superior DNA Delivery Efficiency of Multicomponent Lipid Nanoparticles: An In Vitro and In Vivo Study.多组分脂质纳米颗粒卓越DNA递送效率的机制洞察:一项体外和体内研究
ACS Appl Mater Interfaces. 2022 Dec 28;14(51):56666-56677. doi: 10.1021/acsami.2c20019. Epub 2022 Dec 16.
9
Novel lipid combination for delivery of plasmid DNA to immune cells in the spleen.新型脂质复合物用于将质粒 DNA 递送至脾脏中的免疫细胞。
J Control Release. 2021 Feb 10;330:753-764. doi: 10.1016/j.jconrel.2021.01.005. Epub 2021 Jan 8.
10
Intracellular trafficking kinetics of nucleic acid escape from lipid nanoparticles via fluorescence imaging.通过荧光成像研究核酸从脂质纳米颗粒中逃逸的细胞内运输动力学。
Curr Pharm Biotechnol. 2023 Apr 3. doi: 10.2174/1389201024666230403094238.

引用本文的文献

1
Nanomaterial Adjuvants for Veterinary Vaccines: Mechanisms and Applications.用于兽用疫苗的纳米材料佐剂:作用机制与应用
Research (Wash D C). 2025 Jul 8;8:0761. doi: 10.34133/research.0761. eCollection 2025.
2
Advances in the Functionalization of Vaccine Delivery Systems: Innovative Strategies and Translational Perspectives.疫苗递送系统功能化的进展:创新策略与转化前景
Pharmaceutics. 2025 May 12;17(5):640. doi: 10.3390/pharmaceutics17050640.